Zobrazeno 1 - 8
of 8
pro vyhledávání: '"persistent or recurrent disease"'
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
IntroductionThe personalized management of differentiated thyroid cancer (DTC) is currently based on the postoperative TNM staging system and the ATA risk stratification system (RSS), both updated in 2018 and 2015, respectively.PurposeWe aimed to eva
Externí odkaz:
https://doaj.org/article/8b40382b9f6645ffa39471ba4eef62e2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Fabiana Trulli, Livia Lamartina, Cosimo Durante, Antonella Verrienti, Marianna Maranghi, Sebastiano Filetti, Stefania Lupo, Giuseppe Costante, Marco Biffoni, Laura Giacomelli, Giorgio Grani, Marialuisa Sponziello, Katia Plasmati
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 101:3036-3044
Context:The European Thyroid Association (ETA) has classified posttreatment cervical ultrasound findings in thyroid cancer patients based on their association with disease persistence/recurrence.Objective:The objective of the study was to assess this
Autor:
Marina Carvalho Souza Côrtes, Maria Regina Calsolari, Gabriela Franco Mourão, Pedro Weslley Rosario
Publikováno v:
Brazilian Journal of Otorhinolaryngology v.84 n.4 2018
Brazilian Journal of Otorhinolaryngology
Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)
instacron:ABORL-CCF
Brazilian Journal of Otorhinolaryngology, Vol 84, Iss 4, Pp 448-452 (2018)
Brazilian Journal of Otorhinolaryngology, Volume: 84, Issue: 4, Pages: 448-452, Published: AUG 2018
Brazilian Journal of Otorhinolaryngology
Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial (ABORL-CCF)
instacron:ABORL-CCF
Brazilian Journal of Otorhinolaryngology, Vol 84, Iss 4, Pp 448-452 (2018)
Brazilian Journal of Otorhinolaryngology, Volume: 84, Issue: 4, Pages: 448-452, Published: AUG 2018
Introduction: In patients with papillary thyroid carcinoma who have negative serum thyroglobulin after initial therapy, the risk of structural disease is higher among those with elevated antithyroglobulin antibodies compared to patients without antit
Publikováno v:
Archives of Endocrinology and Metabolism, Volume: 59, Issue: 4, Pages: 285-291, Published: AUG 2015
Archives of Endocrinology and Metabolism, Vol 59, Iss 4, Pp 285-291
Archives of Endocrinology and Metabolism v.59 n.4 2015
Arquivos de Endocrinologia e Metabolismo
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Archives of Endocrinology and Metabolism, Vol 59, Iss 4, Pp 285-291
Archives of Endocrinology and Metabolism v.59 n.4 2015
Arquivos de Endocrinologia e Metabolismo
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM
Objective Lymph node metastases (LNM) are frequent in patients with papillary thyroid cancer (PTC). The risk of persistent disease (PD) and tumor recurrence (TR) is increased when factors for poor prognosis other than LNM exist, when LNM are numerous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2bc9c66f3d5d27478f8dcbcffb87a23
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972015000400285&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972015000400285&lng=en&tlng=en
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 59, Iss 4, Pp 285-291
Objective Lymph node metastases (LNM) are frequent in patients with papillary thyroid cancer (PTC). The risk of persistent disease (PD) and tumor recurrence (TR) is increased when factors for poor prognosis other than LNM exist, when LNM are numerous
Externí odkaz:
https://doaj.org/article/2f2b67c8ac16486d8c7e83ccabb93d07
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.